IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q2 2014 Holdings

Filed 2014-08-14 | 15 holdings | $294.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ariad Pharmaceuticals IncCOM04033A100$76.4K12,000,00026.0%
Idenix Pharmaceuticals IncCOM45166R204$48.2K2,000,00016.4%
Quest Diagnostics Inc(DGX)COM74834L100$45.5K775,00015.5%
Bio-Reference Labs IncCOM $.01 NEW09057G602$38.7K1,280,98413.2%
Merck & Co Inc New(MRK)COM58933Y105$23.1K400,0007.9%
Repros Therapeutics IncCOM NEW76028H209$17.4K1,003,3675.9%
Vivus IncCOM928551100$13.7K2,573,9434.7%
Amgen Inc(AMGN)COM031162100$5.3K45,0001.8%
Aveo Pharmaceuticals Inc(AVEOEUR)COM053588109$4.7K2,570,7591.6%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$4.5K105,0001.5%
Kindred Biosciences IncCOM494577109$4.3K228,1261.4%
Laboratory Corp Amer HldgsCOM NEW50540R409$3.9K37,8241.3%
Intra Cellular Therapies Inc(ITCIEUR)COM46116X101$3.6K215,2021.2%
Targacept IncCOM87611R306$2.8K630,0001.0%
Onconova Therapeutics IncCOM68232V108$1.9K350,0000.6%